Webinar: The Swiss Market and Opportunities for Biotechnology and e-Health Companies:
Swiss Biotech Day 2026: Estonian delegation
Swiss Biotech Day 2026:
0%
panel and round table discussions
0%
partnering conversations
0%
exhibitors
Estonian Delegation
The delegation will be part of the Global Village, which, in partnership with leading Swiss multinational organizations, serves as a premier platform for SBD delegations and fosters international collaboration & networking in the biotech and life sciences industries.
Preliminary Programme
Subject to Change
DAY 0 – Sunday, 3 May 2026
Location: Markthalle Basel, Steinentorberg 20, 4051 Basel
Evening
17:30–20:30
Early arrival welcome reception
DAY 1 – Monday, 4 May 2026
Swiss Biotech Day
Congress Center Basel, Messeplatz 21, 4058 Basel
Congress Center Basel, Messeplatz 21, 4058 Basel
Morning
09:30
Early bird badge pick-up
11:00
Opening Ceremony Global Village
Estonian team, please gather at 10:45 am at the Estonian booth GV21C – Global Village is in Room San Francisco.
Level 3, Estonian pop-up booth: GV21C
Floor map
Level 3, Estonian pop-up booth: GV21C
Floor map
Daytime
11:30–13:30
Lunch
Hall 4.0, Level 0 + Foyer, Level 2
12:30
Plenary session
Room Montreal, Level 2
Day continues with various activities on different floors:
Presentations, panel discussions, pitching sessions, partnering
Presentations, panel discussions, pitching sessions, partnering
Hall 4.1, Level 1
Evening
17:00–17:30
Round table Estonia-Lithuania
“Scaling successful collaboration models between Switzerland and the Baltics in life sciences”
Room San Francisco, Level 3
18:00–18:45
International reception
Room San Francisco, Level 3
18:45–21:00
Evening reception
Hall 4.0, Level 0 + Foyer, Level 2
DAY 2 – Tuesday, 5 May 2026
Congress Center Basel, Messeplatz 21, 4058 Basel
Morning
09:00
Start of the 2nd expo day
Daytime
Exhibition, Global Village, mentoring booths, Swiss cluster booths, presentations, pitching sessions, panel discussions, partnering
Hall 4.1, Level 1
Global Village location: Room San Francisco, Level 3
Global Village location: Room San Francisco, Level 3
10:30
Gathering & walk to Roche manufacturing site
Estonian delegation meets at 10:30 in front of Congress Center (outside). Walk to Roche approx. 15–20 mins.
11:00–12:00
Visit to Roche Basel Drug Substance Manufacturing Site
Next to Roche Building 2, Grenzacherstrasse 124, Basel
Visit is together with Lithuanian delegation
Visit is together with Lithuanian delegation
12:00–13:30
Group lunch with Roche
15:30–16:30
Marketplace at Global Village
Room San Francisco, Level 3
Estonian booth: GV21C
Estonian booth: GV21C
Evening
16:45–18:30
Evening reception
Hall 4.1, Level 1 + Foyer, Level 2
18:00–20:00
Baltic Life Sciences and INNOSUISSE networking reception
Estonian, Lithuanian and INNOSUISSE delegations
Hyperion Hotel Basel, Messepl. 12, 4058 Basel, Switzerland
Hyperion Hotel Basel, Messepl. 12, 4058 Basel, Switzerland
DAY 3 – Wednesday, 6 May 2026
Optional Programme
Special programme options
Global Village side visit programme, organized by Switzerland Global Enterprise.
Two parallel tracks will be organised for visiting Swiss innovation centers: 1) Basel and Zurich
2) Lausanne
2) Lausanne
Separate registration was required.
Eureka Global Innovation Summit 2026
Messe Basel, Messeplatz 10, Event Hall
Separate registration was required.
Estonia at the Global Village
Estonia will be represented at the Swiss Biotech Day Global Village by the Embassy of Estonia, Tartu Biotechnology Park and Enterprise Estonia at a small, compact booth (No. GV21c).
Global Village participation offers the following advantages for Estonian companies:
- Dedicated exclusive Global Village programme with several engagement opportunities
- Publication of a profile on the event website
- International reception for networking with other delegates
- Early arrival reception on May 3rd
- Lunches on May 4th and 5th
- Side visits to Swiss Biotech hotspots (transportation cost is individual).
- Access to “Partnering” (opens March 17th)
- Swiss market introduction webinar on 23rd of March and pre-visit briefing webinar in April
- Special program for Baltic delegations (roundtable and networking opportunities)
- Free access to Eureka Innovation Summit on May 6th
- Coordination support by organizer team
Not Included in the Global Village Package:
- Conference ticket (reduced rate available for participating members 500 CHF instead of 750 CHF).
- Travel and accommodation. Read more here.
- Other related costs (i.e. breakfasts and dinners).
TBD Pharmatech
TBD Pharmatech is a CDMO based in Estonia, EU, specializing in small-molecule APIs and fine chemicals. We support both generic and innovative products for human and veterinary use, offering end-to-end services from early development to commercial manufacturing across a wide range of scales. Our GMP-certified facilities and license to handle controlled substances ensure reliable, compliant and high-quality services.
CHEmesTMED
CHEmesTMED is a preclinical-stage biotech company developing small molecules that repair RNA m6A methylation, a key regulator of gene expression. By restoring proper m6A balance, it aims to address diseases driven by m6A deficiency, including CNS and metabolic disorders, as well as tumours requiring precise enzyme regulation. This approach opens a path toward first-in-class therapies targeting RNA epigenetics.
Selfdiagnostics
Selfdiagnostics is a technology-driven company building and scaling ventures in life science. Its portfolio includes molecular POC diagnostics (SelfDiagnostics), AI health platforms (VitalWatch), mRNA drug delivery platform (GlassPearl), and biomanufacturing solutions (CogniFlow). The company focuses on globally scalable, high-impact technologies that address major global health challenges and improve quality of life.
Metrosert
Metrosert Applied Research Centre connects science & industry to turn knowledge into practical, market-ready solutions. It supports organisations across the innovation process, from applied research and validation to piloting and scaling. The centre focuses on health data, autonomous systems, hydrogen technologies, and biorefining – helping bring new technologies into real-world use.
Vectiopep
Vectiopep is developing peptide-based nucleic acid delivery technologies. Combined with next-generation mRNA therapeutics, it enables the body’s immune system to fight cancer.
The company is a privately held biotechnology firm founded by researchers with over 10 years of experience in developing and optimising nucleic acid delivery systems.
Helmes
Helmes is a leading international software development company delivering business-critical digital solutions for healthcare, life sciences, finance, and government organisations. With strong expertise in AI, data platforms, and regulated environments, Helmes helps ambitious companies scale faster, innovate securely, and turn complex challenges into measurable results.
Partners
